Skip to main content
. 2013 Apr 12;27(6):735–741. doi: 10.1038/eye.2013.56

Table 2. Doppler ultrasound parameters of the subjects.

Groups RPSV of orifice (cm/s) RPSV of hilar (cm/s) APSV (cm/s) RAR
PEX
 Totala, n=98 88.3±30.3 (42–251) 91.7±26.1 (50–175) 76.0±30.7 (30–208) 1.26±0.56 (0.33–3.18)
 HT (+)b, n=34 87.0±29.7 (52–172) 96.9±26.5 (53–169) 76.9±38.8 (30–208) 1.23±0.65 (0.33–3.02)
 HT (−)c, n=64 89.0±31.0 (42–251) 89.4±25.8 (50–175) 75.5±25.7 (43–153) 1.28±0.52 (0.42–3.18)
         
Control
 Totald, n=84 79.5±21.1 (44–138) 93.0±22.6 (48–142) 65.2±17.5 (40–135) 1.23±0.38 (0.61–2.17)
 HT (+)e, n=32 76.5±22.8 (44–138) 87.9±20.9 (56–128) 67.0±16.3 (40–99) 1.14±0.39 (0.66–1.93)
 HT (−)f, n=52 81.4±20.0 (50–120) 96.5±23.2 (48–142) 64.0±18.4 (41–135) 1.29±0.38 (0.61–2.17)

Abbreviations: APSV, abdominal aorta peak systolic velocity; HT, hypertension; n, renal artery; PEX, pseudoexfoliation; RAR, renal-to-aortic ratio; RPSV, renal artery peak systolic velocity.

Independent samples t-test, RPSV of orifice, a vs d, P=0.314; b vs c, P=0.586; e vs f, P=0.778; b vs e, P=0.338; c vs f, P=0.653.

RPSV of hilar, a vs d, P=0.794; b vs c, P=0.511; e vs f, P=0.343; b vs e, P=0.309; c vs f, P=0.640.

APSV, a vs d, P=0.046; b vs c, P=0.881; e vs f, P=0.601; b vs e, P=0.370; c vs f, P=0.065.

RAR, a vs d, P=0.757; b vs c, P=0.634; e vs f, P=0.376; b vs e, P=0.662; c vs f, P=0.366.